Axogen Inc. (0HKD)
LSE
Real-time Data
07:00 AM
Day's Range
40.0052 wk Range
11.25Overview - 0HKD - Axogen Inc.
Key Statistics
Valuation
Enterprise Value
2.60B
Price / Book
‪10.26‬
EV / EBITDA
‪-436.55‬
Profitability
Profit Margin
‪-13.35%‬
Operating Margin
‪-3.09%‬
Return on Assets
‪-3.14%‬
Return on Equity
‪-18.20%‬
Ownership
Shares Outstanding
38.67M
Float
52.61M
Held by Insiders
‪2.16%‬
Held by Institutions
‪99.09%‬
Price stats
Beta
‪1.14‬
50-Day Avg
‪9.10‬
200-Day Avg
‪7.35‬
Peers - 0HKD - Axogen Inc.
Peer Comparison
Compared with companies in Medical Devices listed on LSE.
- 0HKDLSEAxogen Inc.1.56BMarket Cap+70.81%52-week change—P/E (Trailing)‪-13.21%‬Profit Margin
- 0Q15LSEAbbott Laboratories202.01BMarket Cap-13.45%52-week change45.46P/E (Trailing)‪12.91%‬Profit Margin
- SVSLSESavills PLC146.86BMarket Cap+10.28%52-week change22.74P/E (Trailing)‪2.49%‬Profit Margin
- 0Y6XLSEMedtronic plc124.60BMarket Cap+0.73%52-week change0.25P/E (Trailing)‪13.20%‬Profit Margin
- 0R2SLSEStryker Corporation122.44BMarket Cap-19.80%52-week change0.64P/E (Trailing)‪14.43%‬Profit Margin
- 0RGTLSEDemant A/S71.43BMarket Cap+10.98%52-week change27.39P/E (Trailing)‪7.55%‬Profit Margin
- 0HOYLSEBoston Scientific Corporation69.84BMarket Cap-108.22%52-week change0.95P/E (Trailing)‪17.49%‬Profit Margin
Profile Summary - 0HKD - Axogen Inc.
About
Axogen Inc. is a leading developer and marketer of innovative surgical solutions for peripheral nerve regeneration and repair. The company specializes in biologically active technologies, including the Avance Nerve Graft, an off-the-shelf processed human nerve allograft that bridges severed peripheral nerves without…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
